CLINICAL_TRIALS
trial_result
· 2019-08-13
Clinical Trial Update: Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating dasatinib in combination with weekly paclitaxel for metastatic breast cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-13